Search

Discover what Memorial Sloan Kettering contributed to the science and medicine of x-rays.

… Tuesday, October 4, 2016 Summary Since 1902, Memorial Sloan Kettering has been a pioneer in the science and medicine of x-rays, developing many of the radiation techniques in use today. In a previous post , we recounted the history of radium therapy at Memorial Sloan Kettering. Radium, a naturally occurring

Investigators at Memorial Sloan Kettering Cancer Center, along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large-scale, multi-institutional study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.

… Monday, July 27, 2009 Investigators at Memorial Sloan Kettering Cancer Center (MSKCC), along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large- scale, multi-institutional study of prostate cancer death after standard treatment to remove the

Learn about insights that could lead to a new class of drugs against cancers caused by RAS gene mutations.

… Wednesday, October 30, 2024 Each year, more than 3 million people are diagnosed with cancers driven by mutations in three RAS-family genes: KRAS, NRAS , and HRAS . RAS-family mutations are associated with numerous types of cancer. KRAS mutations are found in pancreatic cancer ,  colorectal cancer , 

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.

… Monday, December 10, 2018 Summary A new class of drugs called CDK4/6 inhibitors has been effective in women with breast cancer . However, some people don’t respond to the drugs, or they develop resistance over time. A study by MSK researchers has identified two genes linked to this resistance. The most

MSK performs the highest number of robot-assisted surgeries for colorectal cancer in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.

… Thursday, March 14, 2024 When Robert Mendys was diagnosed with stage 3  rectal cancer  almost 10 years ago, he faced a profound dilemma. He wanted to make sure the cancer didn’t take him away from his wife and three young sons. But at only 46, he was very concerned about the long-term effects of surgical

MSK realiza la mayor cantidad de cirugías asistidas por robot para el cáncer colorrectal en los Estados Unidos, lo que permite que más pacientes tengan una estadía hospitalaria más corta y una recuperación más rápida.

… Thursday, March 14, 2024 Cuando Robert Mendys fue diagnosticado con cáncer de recto en estadio 3 hace casi 10 años, se enfrentó a un profundo dilema. Quería asegurarse de que el cáncer no lo alejara de su esposa y sus tres niños. Pero con solo 46 años, estaba muy preocupado por los efectos a largo plazo

Learn how MSK specialists treat head and neck cancers using the most innovative approaches.

… Monday, May 1, 2017 Summary The chief of the Head and Neck Service describes Memorial Sloan Kettering’s expertise in diagnosing and treating these diseases. In recognition of Head and Neck Cancer Awareness Month, we asked Richard Wong, Chief of the Head and Neck Service, to discuss his team’s approach

The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.

… Monday, February 8, 2021 Summary A unique collaboration among experts from several areas within MSK leads to findings about how inflammation appears to be driving the neurologic effects seen in some COVID-19 patients. One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.

… Wednesday, May 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12),

Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.

… Tuesday, December 6, 2022 Numerous developments in cellular therapy, multiple myeloma, leukemia, and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting , which runs December 10-13. Below are some highlights